Share

September 28, 2020Review

Wearables for Neurologic Conditions: Considerations for our Patients and Research Limitations

Mia T. Minen, Eric J. Stieglitz
First published September 28, 2020, DOI: https://doi.org/10.1212/CPJ.0000000000000971
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
48

Share

Article Information

10.1212/CPJ.0000000000000971
DOI: 
https://doi.org/10.1212/CPJ.0000000000000971
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received January 24, 2020
  • Accepted July 7, 2020
  • First Published September 28, 2020.
Copyright & Usage: 
© 2020 American Academy of Neurology

Author Disclosures

    1. Mia T. Minen, MD, MPH1,* and
    2. Eric J. Stieglitz, JD2
  1. Mia T. Minen, MD, MPH1,* and
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. I have received honoraria from Barnard College for speaking about the field of Neurology. I received the National Headache Foundation Lectureship Award which included a gift/honoraria which covered the cost of attending the meeting.

    Editorial Boards:

    1. Headache: The journal of head and face pain, Associate Editor, Summer 2016-Present, Assistant Editor, Summer 2014-Summer 2015 Pain Medicine, Co-Head of the Headache Section of Pain Medicine, Summer 2016-Summer 2018 (Editorial Member), Summer 2018-Present (Section co-Head)

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Dr. Mia Minen, a research study doctor, contributed to developing intellectual property being used in this study that is co-owned by NYU and IRODY. If the research is successful, NYU and IRODY may benefit from the outcome.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NCCIH grant number AT009706, 2018

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. National Multiple Sclerosis Society International Headache Society Doris Duke Fellowship to Retain Clinician Scientists

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Eric J. Stieglitz, JD2
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. None for me. Wife received National Headache Foundation Lectureship award.

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. None for me. Wife is associate editor for Headache; co-head of Headache section for Pain Medicine.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Wife helped develop the intellectual content of the RELAXaHEAD smartphone app. The app has shared IP between NYU and IRODY. I am an attorney who represents clients. I am not aware of any conflicts between this article and my clients.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. None for me. Wife receives grant K23 AT009706 from NIH.

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. None for me. Wife receives Doris Duke fellowship to retain clinician scientists.

    Stock/Stock Options/Board of Directors Compensation:

    1. I own mutual funds that usually make distributions however I do not know their holdings; please contact me if you require further information.

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. As stated above, I own shares in mutual funds for which I do not know their holdings. Stock/Stock Options, Medical Equipment & Materials: As stated above, I own shares in mutual funds for which I do not know their holdings.

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. I am an attorney who has represented many clients in litigation and other activities over the past two years. I am not aware of any conflict between any client I have had in the past two years and this article. If you require further information, please contact me.

  1. 1 Mia T. Minen MD, MPH,Associate Professor, Chief of Headache Research,Division of Headache Medicine, NYU Langone Departments of Neurology and Population Health, New York, NY
  2. 2 Eric J. Stieglitz, JD, CIPPA/US,Technology Attorney
  1. ↵*Corresponding author: Mia T. Minen, MD, MPH; e-mail: minenmd{at}gmail.com

Article usage

Article usage: September 2020 to January 2021

AbstractFullPdfSource
Sep 20207403Highwire
Oct 2020246025Highwire
Nov 20209907Highwire
Dec 20208805Highwire
Jan 20215008Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

NOTE: All contributors' disclosures must be entered and current in our database before comments can be posted. Enter and update disclosures at http://submit.cp.neurology.org. Exception: replies to comments concerning an article you originally authored do not require updated disclosures.

  • Stay timely. Submit only on articles published within the last 8 weeks.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • 200 words maximum.
  • 5 references maximum. Reference 1 must be the article on which you are commenting.
  • 5 authors maximum. Exception: replies can include all original authors of the article.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on The Nerve!

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate The Nerve! Submission Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me